Richard P. Nordan - Concepedia

Concepedia

Author

Richard P. Nordan

National Cancer Institute

Also Known As

R Nordan, R P Nordan, R. Nordan, R. P. NORDAN, R. P. Nordan, R.P. Nordan, RICHARD P. NORDAN, Richard Nordan, Richard P Nordan, Richard P. Nordan

41

Publications

3.7K

Citations

23

H-Index

70

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Biologics Evaluation and Research National Institute of Allergy and Infectious Diseases Department of Health and Human Services

RP

About

Richard P. Nordan is an author at National Cancer Institute specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	21	3.1K
2	Cell Biology	16	18	3K
3	Allergy	5	5	527
4	Health Sciences	2	2	295
5	Natural Sciences	2	2	86

Richard P. Nordan

×

29

Publications

3.7K

Citations

23

H-Index

	Year	Citations
Mast cell lines produce lymphokines in response to cross-linkage of FcεRI or to calcium ionophores Marshall Plaut, Jacalyn H. Pierce, Cynthia J. Watson, Nature Signal TransductionMast Cell LinesMast Cell DisorderCell TraffickingCell Interaction	1989	1.2K
A Macrophage-Derived Factor Required by Plasmacytomas for Survival and Proliferation in Vitro Richard P. Nordan, Michael Potter Science Plasmacytoma GrowthImmunologyPathologyCell DeathImmunologic Mechanism	1986	384
Interleukin 6 reduces lipoprotein lipase activity in adipose tissue of mice in vivo and in 3T3-L1 adipocytes: a possible role for interleukin 6 in cancer cachexia. Andrew S. Greenberg, Richard P. Nordan, Joe McIntosh, PubMed Fat ReservesImmunologyPathologyMetabolic RemodelingInflammation	1992	280
Recombinant interleukin 7, pre-B cell growth factor, has costimulatory activity on purified mature T cells. Philip Morrissey, Raymond G. Goodwin, Richard P. Nordan, The Journal of Experimental Medicine Recombinant Interleukin 7Lymphocyte DevelopmentAdaptive Immune SystemT-regulatory CellImmune Regulation	1989	225
Expression of the interleukin 6 receptor and interleukin 6 in prostate carcinoma cells. Clay B. Siegall, G Schwab, Richard P. Nordan, PubMed Cancer ResearchCytokineUrologyProstatic Carcinoma CellsMedicine	1990	154
Purification and NH2-terminal sequence of a plasmacytoma growth factor derived from the murine macrophage cell line P388D1. Richard P. Nordan, Janet G. Pumphrey, Stuart Rudikoff The Journal of Immunology Lymphocyte DevelopmentImmunologyImmune RegulationPathologyImmunophenotyping	1987	145
Suramin interferes with interleukin-6 receptor binding in vitro and inhibits colon-26-mediated experimental cancer cachexia in vivo. Gideon Strassmann, M Fong, Carl E. Freter, Journal of Clinical Investigation	1993	132
B cell growth and differentiation activity of interleukin‐hp1 and related murine plasmacytoma growth factors. synergy with interleukin 1 Anne Vink, Pierre G. Coulie, Pierre Wauters, European Journal of Immunology	1988	125
IL-6 is a potent cofactor of IL-1 in IgM synthesis and of IL-5 in IgA synthesis. Dennis Kunimoto, Richard P. Nordan, Warren Strober The Journal of Immunology Lymphocyte DevelopmentImmune RegulationImmunologyPatch B CellsImmunologic Mechanism	1989	124
In vivo induction of IL-6 by administration of exogenous cytokines and detection of de novo serum levels of IL-6 in tumor-bearing mice. Joe McIntosh, David M. Jablons, James J. Mulé, The Journal of Immunology ImmunologyImmunologic MechanismVivo InductionSerum Il-6Immune Dysregulation	1989	117

Page 1